Brigitte Michelsen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.
Journal: EULAR rheumatology open
Published: June 29, 2026
Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.
Journal: EULAR rheumatology open
Published: June 29, 2026
Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.
Journal: The Journal of rheumatology
Published: June 15, 2026
Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.
Journal: The Journal of rheumatology
Published: June 15, 2026
Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries.
Journal: Annals of the rheumatic diseases
Published: February 20, 2026
Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.
Journal: Annals of the rheumatic diseases
Published: February 11, 2026
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.
Journal: ACR open rheumatology
Published: April 17, 2025
Preterm birth in women with psoriatic arthritis: what are the risks and risk factors? A collaborative cohort study from Sweden, Denmark and Norway.
Journal: RMD open
Published: February 26, 2025
Last Updated: 09/26/2026